Skip to main content
. Author manuscript; available in PMC: 2012 Jun 4.
Published in final edited form as: Behav Pharmacol. 2011 Apr;22(2):101–112. doi: 10.1097/FBP.0b013e3283425028

Appendix 1.

Averaged Range values for individual subjects during all vehicle and drug doses of d-amphetamine, nicotine, and haloperidol

D-amphetamine Nicotine Haloperidol



S V 0.3 1.0 1.7 2.25 3.0 V 0.03 0.1 0.3 1.0 1.7 V 0.01 0.03 0.1 0.3 0.5 0.7
L 673 0.87 0.88 0.91 0.88 0.86 0.67 0.94 1.00 0.96 0.86 0.74 0.72 0.93 0.95 0.96 0.89 0.88 0.88 0.89
648 0.94 0.95 0.91 0.77 0.56 0.80 0.97 1.02 0.94 0.89 0.88 0.92 0.92 0.98 0.96 0.86 0.75 0.70
622 0.94 0.98 1.00 0.95 0.96 0.94 0.97 0.92 0.96 0.94 0.90 0.86 0.96 0.99 0.96 0.69 0.82 0.62
4423 0.94 0.98 0.86 0.69 0.57 0.60 0.92 0.86 0.82 0.72 0.69 0.98 0.99 0.95 0.94 0.79 0.61
883 1.00 0.98 0.99 0.98 0.91 0.70 1.00 0.98 0.92 0.97 0.81 0.98 0.97 0.96 0.88 0.68 0.76
774 1.01 0.99 0.96 1.00 0.97 0.72 0.97 0.96 0.90 0.83 0.48 0.58 0.98 0.95 0.98 0.91 0.90 0.90 0.69
C 811 0.96 0.92 0.92 0.98 0.86 0.76 0.96 1.00 0.95 0.81 0.92 0.58 0.94 0.94 0.84 0.75 0.71 0.66
965 0.91 0.92 0.68 0.61 0.67 0.42 0.87 1.03 0.93 0.80 0.86 0.72 0.95 0.86 0.93 0.82 0.67 0.61 0.59
642 0.79 0.85 0.81 0.72 0.63 0.92 0.87 0.88 0.82 0.67 0.54 0.90 0.79 0.79 0.76 0.68
657 1.00 0.99 0.93 0.74 0.58 0.95 0.99 0.81 0.71 0.72 0.68 0.99 0.91 0.88 0.92 0.83 0.87
63 0.88 0.87 0.70 0.53 0.58 0.47 0.94 0.96 0.98 0.78 0.70 0.72 0.86 0.91 0.92 0.90 0.77 0.68 0.67
750 0.92 0.92 0.84 0.54 0.46 0.96 0.85 0.82 0.75 0.65 0.64 0.97 0.95 0.98 0.82 0.81 0.69 0.68

Location subjects (L) are in the top six rows, whereas Color subjects (C) are in the bottom six rows. Missing values indicate that the subject (S) did not receive that particular dose of drug. V, vehicle.